2:58 PM
 | 
Jul 10, 2018
 |  BC Extra  |  Company News

BioCryst, Idera drop merger plans

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said it terminated its merger agreement with Idera Pharmaceuticals Inc. (NASDAQ:IDRA) after BioCryst stockholders...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >